Paper714156
A better cell line for making hybridomas secreting specific antibodies.
Shulman M and 2 others. Nature, 1978. Cited by 1,553 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. A better cell line for making hybridomas secreting specific antibodies. Papers, record 714156. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/714156
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Source Cell lines
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibody Formation | Major topic |
| Cell Line | Major topic |
| Hybrid Cells | Major topic |
| Multiple Myeloma | Major topic |
| Antibody Specificity | |
| Clone Cells | |
| Myeloma Proteins | |
| Spleen |
Source PubMed
Cited by423
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1,553 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,939,752 | Anti-TIM-4 Monoclonal Antibody Treatment Reduces Autoreactive CD8+ T Cells and Restores Euglycemia in New-Onset Diabetic NOD Mice. | Biomolecules | 2026 | https://conductscience.org/library/papers/42939752 | PubMed |
| 42,793,264 | Rapid Generation of High-Affinity Rabbit Anti-Mouse IgG Monoclonal Antibodies by High-Throughput Single-B-Cell Sorting and Recombinant Expression. | Curr Issues Mol Biol | 2026 | https://conductscience.org/library/papers/42793264 | PubMed |
| 42,645,424 | Functional Parameters of Hybridoma Cells: Methods of Evaluation and Biotechnological Relevance. | Antibodies (Basel) | 2026 | https://conductscience.org/library/papers/42645424 | PubMed |
| 40,814,003 | Development and characterization of monoclonal antibodies specific for bovine IP-10. | Vet Res | 2025 | https://conductscience.org/library/papers/40814003 | PubMed |
| 40,723,893 | Generation of Novel Monoclonal Antibodies Recognizing Rabbit CD34 Antigen. | Biomolecules | 2025 | https://conductscience.org/library/papers/40723893 | PubMed |
| 39,584,990 | A Brief Chronicle of Antibody Research and Technological Advances. | Antibodies (Basel) | 2024 | https://conductscience.org/library/papers/39584990 | PubMed |
| 38,474,105 | Rapid and Convenient Single-Chain Variable Fragment-Employed Electrochemical C-Reactive Protein Detection System. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38474105 | PubMed |
| 37,758,930 | High-volume hybridoma sequencing on the NeuroMabSeq platform enables efficient generation of recombinant monoclonal antibodies and scFvs for neuroscience research. | Sci Rep | 2023 | https://conductscience.org/library/papers/37758930 | PubMed |
| 35,881,361 | Production of PfEMP1-Specific Mouse Monoclonal Antibodies. | Methods Mol Biol | 2022 | https://conductscience.org/library/papers/35881361 | PubMed |
| 34,816,397 | Mammalian Cell Culture as a Platform for Veterinary Vaccines. | Methods Mol Biol | 2022 | https://conductscience.org/library/papers/34816397 | PubMed |
| 34,745,567 | Methods to measure calcitonin receptor activity, up-regulated in cell stress, apoptosis and autophagy. | F1000Res | 2021 | https://conductscience.org/library/papers/34745567 | PubMed |
| 34,661,773 | Hybridoma technology; advancements, clinical significance, and future aspects. | J Genet Eng Biotechnol | 2021 | https://conductscience.org/library/papers/34661773 | PubMed |
| 34,634,047 | A hybridoma-derived monoclonal antibody with high homology to the aberrant myeloma light chain. | PLoS One | 2021 | https://conductscience.org/library/papers/34634047 | PubMed |
| 34,415,957 | Determination of variable region sequences from hybridoma immunoglobulins that target Mycobacterium tuberculosis virulence factors. | PLoS One | 2021 | https://conductscience.org/library/papers/34415957 | PubMed |
| 33,891,595 | New monoclonal antibodies that recognize an unglycosylated, conserved, extracellular region of CD44 in vitro and in vivo, and can block tumorigenesis. | PLoS One | 2021 | https://conductscience.org/library/papers/33891595 | PubMed |
| 33,151,102 | A monoclonal antibody with broad specificity for the ligands of insulin B:9-23 reactive T cells prevents spontaneous type 1 diabetes in mice. | MAbs | 2020 | https://conductscience.org/library/papers/33151102 | PubMed |
| 32,799,164 | Generation of functional single-chain fragment variable from hybridoma and development of chemiluminescence enzyme immunoassay for determination of total malachite green in tilapia fish. | Food Chem | 2021 | https://conductscience.org/library/papers/32799164 | PubMed |
| 32,473,573 | Hybridoma technology a versatile method for isolation of monoclonal antibodies, its applicability across species, limitations, advancement and future perspectives. | Int Immunopharmacol | 2020 | https://conductscience.org/library/papers/32473573 | PubMed |
| 32,448,385 | Cartilage-binding antibodies initiate joint inflammation and promote chronic erosive arthritis. | Arthritis Res Ther | 2020 | https://conductscience.org/library/papers/32448385 | PubMed |
| 32,209,676 | Neutralizing Monoclonal Antibodies against the Gn and the Gc of the Andes Virus Glycoprotein Spike Complex Protect from Virus Challenge in a Preclinical Hamster Model. | mBio | 2020 | https://conductscience.org/library/papers/32209676 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/714156
GET https://conductscience.org/api/papers/v1/714156/cited_by?page=2